EP3579837

AXITINIB, NINTEDANIB OR LENVATINIB FOR THE TREATMENT OF ROSACEA AND ATOPIC DERMATITIS

  • :
    EP einkaleyfi: Þýðing ekki lögð inn
  • :
    12.2.2018
  • :
    7.6.2023
  • :
    18751042.5
  • :
    11.2.2038
  • :
    AXITINIB, NINTEDANIB OR LENVATINIB FOR THE TREATMENT OF ROSACEA AND ATOPIC DERMATITIS

12.2.2018
7.6.2023
  • :
    AiViva Biopharma, Inc.
  • :
    848 North Rainbow Boulevard, Suite 2654, Las Vegas, NV 89107, US
  • :
    TANG-LIU, Diane
  • :
    Las Vegas, NV 89107, US
  • :
    DEVRIES, Gerald, Woodrow
  • :
    San Clemente, CA 92673, US
  • :
    201762457929 P
  • :
    12.2.2017
  • :
    US
  • :
    US2018017810
  • :
    12.2.2018
  • :
    A61K 31/4439, A61K 31/496, A61K 31/47, A61P 17/00, A61P 17/02, A61P 17/06, A61K 9/00